Shoichiro Yamamoto

Ehime University Graduate School of Medicine

Japan

  • Ehime University Graduate School of Medicine

SCHOLARLY PAPERS

1

DOWNLOADS

34

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

A Phase II Study (WJOG12819L) to Assess the Efficacy of Osimertinib in Patients with EGFR Mutation-Positive NSCLC in Whom Systemic Disease (T790M-Negative) Progressed after Treatment with First- Or Second-Generation EGFR TKIS and Platinum-Based Chemotherapy

Number of pages: 19 Posted: 04 Jan 2023
Masayuki Takeda, Mototsugu Shimokawa, Atsushi Nakamura, Kaname Nosaki, Yasutaka Watanabe, Terufumi Kato, Daisuke Hayakawa, Hiroshi Tanaka, Toshiaki Takahashi, Masahide Oki, Motoko Tachihara, Daichi Fujimoto, Hidetoshi Hayashi, Kakuhiro Yamaguchi, Shoichiro Yamamoto, Eiji Iwama, Koichi Azuma, Kazuo Hasegawa, Nobuyuki Yamamoto and Kazuhiko Nakagawa
Kindai University, Yamaguchi University, Sendai Kousei Hospital, National Cancer Center Hospital East, Saitama Cancer Center, Kanagawa Cancer Center, Juntendo University - Juntendo University Hospital, Niigata Cancer Center Hospital, Shizuoka Cancer Center, National Hospital Organization Nagoya Medical Center, Kobe University, Wakayama Medical University, Kindai University, Hiroshima University - Hiroshima University Hospital, Ehime University Graduate School of Medicine, Kyushu University - Kyushu University Hospital, Kurume University - Department of Internal Medicine, Japan Lung Cancer Alliance, Wakayama Medical University - Department of Pulmonary Medicine and Medical Oncology and Kindai University
Downloads 34 (1,011,955)

Abstract:

Loading...

lung cancer, EGFR, T790-negative, Osimertinib, Patient-initiated clinical trial